Gilbert & Cook’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
3,994
+90
| +2% | +$29.3K | 0.18% | 55 |
|
|
2025
Q1 | $1.05M | Hold |
3,904
| – | – | 0.15% | 60 |
|
|
2024
Q4 | $919K | Sell |
3,904
-20
| -0.5% | -$4.71K | 0.13% | 74 |
|
|
2024
Q3 | $1.08M | Sell |
3,924
-137
| -3% | -$37.7K | 0.15% | 65 |
|
|
2024
Q2 | $987K | Sell |
4,061
-424
| -9% | -$103K | 0.14% | 65 |
|
|
2024
Q1 | $670K | Buy |
4,485
+42
| +0.9% | +$6.28K | 0.09% | 106 |
|
|
2023
Q4 | $850K | Buy |
4,443
+317
| +8% | +$60.7K | 0.12% | 77 |
|
|
2023
Q3 | $731K | Buy |
4,126
+2,766
| +203% | +$490K | 0.12% | 82 |
|
|
2023
Q2 | $258K | Buy |
+1,360
| New | +$258K | 0.04% | 184 |
|